Music for Anxiety in Critically Ill Patients
RELACS
Result of a Music Intervention on Anxiety in Critically Ill Patients
1 other identifier
interventional
104
1 country
3
Brief Summary
Rationale: Anxiety is common in critically ill patients, and has likely become more prevalent in the recent decade due to the imperative of the recent PADIS guidelines to use low levels of sedation and strive for wakefulness. Administration of sedative and analgesic medication is often chosen to reduce anxiety, especially when associated with agitation, but especially sedatives are associated with prolonged mechanical ventilation, delirium and muscle wasting and are therefore preferably minimized. Previous studies have suggested positive effects of music interventions on anxiety in the critically ill, next to other physiological signs such as pain. However, management of anxiety has not been included in the PADIS guidelines, and there is lack of evidence to treat it in spite of its growing importance. Therefore, we aim to study the effect of music intervention on anxiety in adult critically ill patients. Objective: The primary objective is to assess the effect of music intervention on the level of anxiety. Study design: A randomized controlled trial. Study population: Adult patients admitted to the intensive care unit, with whom communication is possible (Richmond Agitation Sedation Scale of -2 or higher). Intervention (if applicable): The music group will be offered to listen to music two times per day for three days after inclusion, during 30-60 minutes per session. Chosen music will be based on the preference of the patient. The control group will receive standard of care during the entire study. Main study parameters/endpoints: The primary outcome is the effect of music on the Visual Analogue Scale for anxiety (VAS-A). Secondary outcomes include effect of music on sedation and agitation level, medication requirement, pain, sleep, delirium, heart rate, mean arterial pressure, and ICU memory and experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Aug 2020
Typical duration for not_applicable anxiety
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2020
CompletedFirst Submitted
Initial submission to the registry
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedApril 13, 2022
April 1, 2022
1.3 years
March 4, 2021
April 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety (VAS-A)
Measured using the Visual Analogue Scale for Anxiety (VAS-A), on a scale of 0 to 10, in which a higher score means a worse outcome.
1.5 year
Secondary Outcomes (10)
Anxiety (STAI-6)
1.5 year
Sleep quality
1.5 year
Delirium
1 year
Sedative and opioid medication requirement
1.5 year
ICU memory and experience
1.5 year
- +5 more secondary outcomes
Other Outcomes (2)
ICU length of stay
1.5 year
Mechanical ventilation
1.5 year
Study Arms (2)
Recorded music
EXPERIMENTALRecorded music intervention
Control
NO INTERVENTIONStandard of care
Interventions
Eligibility Criteria
You may qualify if:
- Expected ICU stay upon randomisation of at least another 48 hours.
- Written informed consent acquired from the patient or legal representative.
You may not qualify if:
- Patients with severe hearing impairment, defined as no verbal communication possible.
- Neurological condition (e.g. severe stroke), when deemed to interfere with processing of music (e.g. not applicable to patients with minor stroke in past medical history without significant residual neurological deficits; those patients could be included).
- Insufficient knowledge of the Dutch or English language for informed consent.
- Participation in another study that may possibly intervene with the primary outcome measure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Erasmus MC
Rotterdam, South Holland, 3015 GD, Netherlands
Ikazia
Rotterdam, South Holland, 3083 AN, Netherlands
HagaZiekenhuis
The Hague, South Holland, 2545 AA, Netherlands
Related Publications (2)
Kakar E, Ottens T, Stads S, Wesselius S, Gommers DAMPJ, Jeekel J, van der Jagt M. Effect of a music intervention on anxiety in adult critically ill patients: a multicenter randomized clinical trial. J Intensive Care. 2023 Aug 17;11(1):36. doi: 10.1186/s40560-023-00684-1.
PMID: 37592358DERIVEDKakar E, Van Mol M, Jeekel J, Gommers D, van der Jagt M. Study protocol for a multicentre randomised controlled trial studying the effect of a music intervention on anxiety in adult critically ill patients (The RELACS trial). BMJ Open. 2021 Oct 12;11(10):e051473. doi: 10.1136/bmjopen-2021-051473.
PMID: 34642197DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mathieu Dr. M. van der Jagt, MD, PhD
Erasmus Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 4, 2021
First Posted
March 12, 2021
Study Start
August 24, 2020
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
April 13, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share